Advanced Practice Midwife in Butte, MT Accepting Medicare

4 Advanced Practice Midwife nurses found. Showing 1 - 4

Rebecca Marie Lopez, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 445 Centennial Ave, Butte, MT 59701 Phone: 406-723-4075    Fax: 406-723-3059

Megan Bristol, MSN, RN, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 400 S Clark St, Butte, MT 59701 Phone: 406-496-3627

Jamie B. Glenn, CNM, MS Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 401 S Alabama St, Suite 1, Butte, MT 59701 Phone: 409-723-8051    Fax: 406-723-8063

Jenevieve Lee Clark, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 400 S Clark St, Butte, MT 59701 Phone: 406-723-2500

News Archive

Exploring factors that need considered before offering genetic risk information to individuals

Should researchers inform research participants, if they discover genetic disease risks in the participants? Yes, many would say, if the information is helpful to the participants.

California lawmakers advance effort to review premium increases

A bill that would allow California officials to review health insurance premium increases advances as consumer groups and doctors in Connecticut lament the governor's veto of a rate review bill. Politico also reports that the federal government is preparing to step in for rate reviews in 10 states.

Pfizer receives positive opinion from EMA CHMP for crizotinib to treat ALK-positive NSCLC

Pfizer announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that crizotinib be granted conditional marketing authorization in the European Union (EU), for the treatment of adults with previously treated anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).

C3BS plans to open new U.S.-based facility to manufacture C-Cure for use in Phase III trial

Cardio3 BioSciences, a leader in the discovery and development of engineered cell therapies, today confirmed plans to open a new U.S.-based manufacturing facility in Rochester, Minnesota. The facility will support the Company's current and anticipated manufacturing needs in the United States for both the Phase III clinical trial evaluating lead cardiovascular product candidate C-Cure (CHART-2), and its recently acquired CAR T-cell therapies' portfolio.

Stuttering is best treated early

About 5% of children begin to stutter, usually in the third and fourth years of life. The consensus is that early intervention in the preschool years is necessary, but evidence to support this is currently lacking.

Read more Medical News

› Verified 6 days ago